How silencing a gene-silencer could lead to new cancer drugs
A new CU Boulder study published in the journal Science reveals how a molecular machine known as PRC2 helps determine which cells become heart cells, vs. brain or muscle or skin cells. The findings shed light on how development occurs and could pave the way for novel cancer treatments.
Source: colorado.edu